The journal

Research notes, lab guides, quality essays.

What we're reading, learning, and shipping. Plain-language notes from the lab.

Research spotlight

BPC-157: A Plain-Language Overview of the Research

What the published preclinical literature has actually explored about BPC-157 — its structure, the research areas it appears in, and the limits of the current evidence. For laboratory and research use only.

July 2, 2026
Quality & testing

How to Read a Compound Certificate of Analysis (CoA)

A plain-language guide to interpreting a compound Certificate of Analysis, from HPLC purity percentages to mass-spectrometry identity confirmation, so laboratory researchers can evaluate what a lot's documentation actually shows.

June 24, 2026
Research spotlight

Tesamorelin: A Research Literature Overview

An educational overview of the published research literature on tesamorelin, a stabilized GHRH analog examined in laboratory and clinical research models in relation to the growth hormone axis and metabolic endpoints.

June 15, 2026
Research spotlight

MOTS-c: An Overview of the Mitochondrial-Compound Research

An educational overview of MOTS-c, a mitochondrial-derived compound studied in preclinical metabolic, exercise, and cellular-stress research models.

June 5, 2026
Research spotlight

NAD+ in Research: A Plain-Language Overview

A plain-language look at what published preclinical research has explored about NAD+ (nicotinamide adenine dinucleotide) in cellular metabolism and aging biology, framed for laboratory and research context only.

May 27, 2026
Research spotlight

Semax: What the Nootropic Compound Research Explores

A research-framed overview of Semax, an ACTH(4-10)-derived compound, and what preclinical laboratory studies have explored regarding neurotrophic signaling, monoamine systems, and models of cognition and ischemia.

May 15, 2026
Research spotlight

Selank: A Plain-Language Research Overview

A plain-language look at Selank, a synthetic tuftsin-analog compound, and what published preclinical research has explored regarding its neurochemistry, framed strictly for laboratory research use.

May 6, 2026
Research spotlight

Retatrutide: The Triple-Agonist Research Story

An educational overview of Retatrutide, an investigational GIP/GLP-1/glucagon triple receptor agonist, and what published preclinical and early-phase research has explored about its mechanism in laboratory and animal models.

April 24, 2026
Research spotlight

Tirzepatide: A GIP/GLP-1 Research Overview

An evergreen research overview of tirzepatide, a dual GIP/GLP-1 receptor agonist compound, summarizing what preclinical laboratory and animal-model studies have explored about its receptor pharmacology and metabolic signaling.

April 13, 2026
Research spotlight

Semaglutide and the GLP-1 Research Landscape

An educational overview of semaglutide, a long-acting GLP-1 receptor agonist, and the preclinical research literature exploring GLP-1 signaling across metabolic, cardiovascular, and neurobiological research models.

April 1, 2026
Research spotlight

CJC-1295 (No DAC): A Research Overview

A laboratory-focused overview of CJC-1295 without DAC (Modified GRF 1-29), a synthetic GHRH analog that has been studied as a tool compound in preclinical models of pituitary growth hormone signaling.

March 20, 2026
Research spotlight

Ipamorelin: An Overview of the Research Literature

A research-focused overview of Ipamorelin, a selective growth-hormone secretagogue compound, summarizing what preclinical laboratory and animal studies have explored about its receptor pharmacology, selectivity, and physiological correlates in research models.

March 9, 2026
Research spotlight

GHK-Cu: What the Copper-Compound Research Explores

An evergreen research overview of GHK-Cu (copper three-amino-acid compound-1), summarizing what preclinical laboratory studies have explored around collagen remodeling, gene expression, and copper biology.

February 25, 2026
Research spotlight

TB-500: A Plain-Language Overview of the Research

A research-focused, plain-language summary of what preclinical studies have explored regarding TB-500, a compound fragment related to the actin-binding protein Thymosin Beta-4.

February 13, 2026

More posts soon. Want a specific topic covered? Tell us.